Pancreatic Cancer Research

ResearcherWuhan Union HospitalNo recent work listed

Fei Han

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 8 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper

Papers 2

  1. ERO1L promotes pancreatic cancer cell progression through activating the Wnt/catenin pathway. Co-author DOI 10.1002/jcb.27155↗
  2. Mutations in the p16 gene in DMBA-induced pancreatic intraepithelial neoplasia and pancreatic cancer in rats. Co-author DOI 10.1016/s1499-3872(15)60331-9↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jun Liu · 1 shared paper, 2018 · strength 0.11
  2. Qianqian Xu · 1 shared paper, 2018 · strength 0.11
  3. Jianguo Zhao · 1 shared paper, 2018 · strength 0.11
  4. Zhu Zhu · 1 shared paper, 2015 · strength 0.06
  5. Chunyou Wang · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.